Parkinson’s Disease
Azamat HEKİMOĞLUa , Güler YAVAŞa
aAnkara Etlik City Hospital, Clinic of Radiation Oncology, Ankara, Türkiye
Hekimoğlu A, Yavaş G. Parkinson’s disease. In: Uysal B, Gamsız H, eds. Current Concepts in Radiotherapy for Benign Disorders. 1st ed. Ankara: Türkiye Klinikleri; 2025. p.52-6.
ABSTRACT
The primary therapeutic approach for conditions characterized by movement disorders, such as Parkinson’s Disease (PD), typically involves pharmacological interventions. However, for a subset of patients unable to derive benefit from medication or encountering intolerable side effects, alternatives such as Deep Brain Stimulation (DBS) or surgical interventions targeting the basal ganglia and thalamus may be considered. Stereotactic radiosurgery (SRS) emerges as a noninvasive alternative for patients for whom medical therapy is contraindicated and surgical options like DBS are not feasible. Although SRS procedures can be performed using various devices like GammaKnife (GK), CyberKnife (CK), and LINAK-based systems, the bulk of research in this realm has been conducted with GammaKnife. Thalamotomy, targeting the ventralis intermedius nucleus (VIM), proves effective in addressing tremors of diverse origins. SRS-assisted thalamotomy has exhibited favorable outcomes in tremor management, with success rates ranging from 70-80%. Conversely, the efficacy of pallidotomy and SRS interventions targeting the internal globus pallidus (Gpi) for addressing bradykinesia, rigidity, and dyskinesia has not paralleled that of thalamotomy, prompting debate with pallidotomy success rates spanning from 0-80%. Notably, the European Academy of Neurology Movement Disorders Association Guidelines caution against the use of Stereotactic Radiosurgery using Gamma radiation due to its associated high risks. However, it is hoped that thalamotomy facilitated by stereotactic radiosurgery will be considered as a viable alternative only within specialized centers experienced in this modality, catering to patients who have exhausted other therapeutic avenues.
Keywords: Parkinson’s disease; stereotactic radiosurgery; CyberKnife; GammaKnife; thalamotomy
Kaynak Göster
Referanslar
- Thenganatt MA, Jankovic J. Parkinson disease subtypes. JAMA Neurol. 2014;71(4):499-504. [Crossref] [PubMed]
- Kalia LV, Lang AE. Parkinson's disease. Lancet. 2015;386(9996):896-912. [Crossref] [PubMed]
- Massano J, Bhatia KP. Clinical approach to Parkinson's disease: features, diagnosis, and principles of management. Cold Spring Harb Perspect Med. 2012;2(6):a008870. [Crossref] [PubMed] [PMC]
- Rao SS, Hofmann LA, Shakil A. Parkinson's disease: diagnosis and treatment. Am Fam Physician. 2006;74(12):2046-54.
- Kim HJ, Mason S, Foltynie T, Winder-Rhodes S, Barker RA, Williams-Gray CH. Motor complications in Parkinson's disease: 13-year follow-up of the CamPaIGN cohort. Mov Disord. 2020;35(1):185-90. [Crossref] [PubMed] [PMC]
- Armstrong MJ, Okun MS. Diagnosis and Treatment of Parkinson Disease: A Review. JAMA. 2020;323(6):548-60. [Crossref] [PubMed]
- Sharma VD, Patel M, Miocinovic S. Surgical Treatment of Parkinson's Disease: Devices and Lesion Approaches. Neurotherapeutics. 2020;17(4):1525- 38. [Crossref] [PubMed] [PMC]
- Young RF, Shumway-Cook A, Vermeulen SS, Grimm P, Blasko J, Posewitz A, et al. Gamma knife radiosurgery as a lesioning technique in movement disorder surgery. J Neurosurg. 1998;89(2):183-93. [Crossref] [PubMed]
- Leksell L. Stereotactic radiosurgery. J Neurol Neurosurg Psychiatry. 1983;46(9):797-803. [Crossref] [PubMed] [PMC]
- Lim SY, Hodaie M, Fallis M, Poon YY, Mazzella F, Moro E. Gamma knife thalamotomy for disabling tremor: a blinded evaluation. Arch Neurol. 2010;67(5):584-8. [Crossref] [PubMed]
- Duma CM, Jacques D, Kopyov OV. The treatment of movement disorders using Gamma Knife stereotactic radiosurgery. Neurosurg Clin N Am. 1999;10(2):379-89. [Crossref] [PubMed]
- Ohye C, Shibazaki T, Ishihara J, Zhang J. Evaluation of gamma thalamotomy for parkinsonian and other tremors: survival of neurons adjacent to the thalamic lesion after gamma thalamotomy. J Neurosurg. 2000;93 Suppl 3:120-7. [Crossref] [PubMed]
- Khattab MH et al. Noninvasive Thalamotomy for Refractory Tremor by Frameless Radiosurgery. Int J Radiat Oncol Biol Phys. 2022;112(1):121-30. [Crossref] [PubMed]
- Goc B, Roch-Zniszczoł A, Larysz D, Zarudzki Ł, Stąpór-Fudzińska M, Rożek A, et al. The Effectiveness and Toxicity of Frameless CyberKnife Based Radiosurgery for Parkinson's Disease-Phase II Study. Biomedicines. 2023;11(2):288. [Crossref] [PubMed] [PMC]
- Friedman JH, Epstein M, Sanes JN, Lieberman P, Cullen K, Lindquist C, et al. Gamma knife pallidotomy in advanced Parkinson's disease. Ann Neurol. 1996;39(4):535-8. [Crossref] [PubMed]
- Young RF, Vermeulen S, Posewitz A, Shumway-Cook A. Pallidotomy with the gamma knife: a positive experience. Stereotact Funct Neurosurg. 1998;70 Suppl 1:218-28. [Crossref] [PubMed]
- Raju SS, Niranjan A, Monaco EA III, Flickinger JC, Lunsford LD. Stereotactic Radiosurgery for Intractable Tremor-Dominant Parkinson Disease: A Retrospective Analysis. Stereotact Funct Neurosurg. 2017;95(5):291-7. [Crossref] [PubMed]
- Young RF, Jacques S, Mark R, Kopyov O, Copcutt B, Posewitz A, et al. Gamma knife thalamotomy for treatment of tremor: long-term results. J Neurosurg. 2000;93 Suppl 3:128-35. [Crossref] [PubMed]
- Friehs GM, Ojakangas CL, Schröttner O, Ott E, Pendl G. Radiosurgical lesioning of the caudate nucleus as a treatment for parkinsonism: a preliminary report. Neurol Res. 1997;19(1):97-103. [Crossref] [PubMed]
- Friehs GM, Ojakangas CL, Pachatz P, Schröttner O, Ott E, Pendl G. Thalamotomy and caudatotomy with the Gamma Knife as a treatment for parkinsonism with a comment on lesion sizes. Stereotact Funct Neurosurg. 1995;64 Suppl 1:209-21. [Crossref] [PubMed]
- Ohye C, Higuchi Y, Shibazaki T, Hashimoto T, Koyama T, Hirai T, et al. Gamma knife thalamotomy for Parkinson disease and essential tremor: a prospective multicenter study. Neurosurgery. 2012;70(3):526-35; discussion 535-6. [Crossref] [PubMed]
- Ohye C, Shibazaki T, Sato S. Gamma knife thalamotomy for movement disorders: evaluation of the thalamic lesion and clinical results. J Neurosurg. 2005;102 Suppl:234-40. [Crossref] [PubMed]
- Deuschl G et al. European Academy of Neurology/Movement Disorder Society-European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies. Mov Disord. 2022;37(7):1360-74.